December 3rd 2024
To proactively reduce the likelihood of a lawsuit, physicians can adopt a strategic approach embodied in the acronym A-V-O-I-D.
November 21st 2024
November 12th 2024
Don’t skimp on your HIPAA risk assessment
November 25th 2015If you’ve ever been speeding down the highway, passed a police car, then slowed to well below the speed limit, hoping you wouldn’t get pulled over and handed a citation, then you are likely doing the same thing when it comes to your HIPAA compliance.
The last word Congress is final hurdle in removing EHR ‘gag clauses’
November 25th 2015Congress will likely move to forbid non-disclosure clauses in EHR contracts with healthcare providers, but final action won’t occur until 2016 when the House and Senate come together to align their different, more far-ranging proposals on EHRs.
Mobile health reduces CVD risk behaviors
November 23rd 2015An American Heart Association Scientific Statement about the feasibility and preliminary efficacy of using mobile health technologies to reduce CVD risk behaviors was the cornerstone of the presentation of Lora E. Burke, PhD at the AHA meeting.
How to identify AF patients at low stroke risk
November 23rd 2015In a presentation at the 2015 AHA Fall Conference, Daniel E. Singer, MD, spoke about identifying patients with an increased bleeding risk with the long-term use of oral anticoagulants and whether or not there is a benefit in those cases.
Management of HBP in the elderly needs individualization
November 23rd 2015In her presentation at the 2015 AHA Fall Conference, Nanette K. Wenger, MD, spoke about management of high blood pressure in the elderly. Wenger showed case studies to illustrate variations of blood pressure among elderly patients and how to manage them.
New hep C guidelines endorse direct-acting anti-viral agents
November 19th 2015Nearly all patients with chronic hepatitis C virus (HCV) infections should receive direct-acting anti-viral agents, according to updated guidelines by the American Association for the Study for Liver Diseases and the Infectious Diseases Society of America.
Predicting the future of Meaningful Use 3
November 17th 2015Medical Economics sat down with John Halamka, MD, MS, to ask questions about the Centers for Medicare & Medicaid Services' issuing of a Final Rule for attesting to Stage 3 of Meaningful Use programs as well as physicians' demands for delays of the 2017 starting.
First take: Why we should reimburse end-of-life discussions
November 10th 2015In this First Take, Linda Cornfield, MD writes how she discusses end-of-life care with patients and their families. End-of-life care is an important and complicated conversation to have with patients and they need help finding their way down this path.